SIETES :: 93212 citas

Resultados de la búsqueda por PROTOCOLOS REFINAR BÚSQUEDA

21.

Ferri M, Abdallah K. Preparing for responsible sharing of clinical trial data. N Engl J Med 2014;370:484-5. [Ref.ID 97071]

22.

Friedman AB. Preparing for responsible sharing of clinical trial data. N Engl J Med 2014;370:484. [Ref.ID 97070]

23.

Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med 2014;370:444-54. [Ref.ID 97065]

24.

Frieden TR, Coleman King SM, Wright JS. Protocol-based treatment of hypertension: a critical step on the pathway to progress. JAMA 2014;311:21-2. [Ref.ID 97031]

25.

Sanfélix-Genovés J, Catalá-López F, Sanfélix-Gimeno G, Hurtado I, Baixauli C, Peiró S. Variabilidad en las recomendaciones para el abordaje clínico de la osteoporosis. Med Clin (Barc) 2014;142:15-22. [Ref.ID 97016]

26.

Saquib N, Saquib J, Ioannidis JPA. Practices and impact of primary outcome adjustment in randomized controlled trials: meta-epidemiologic study. BMJ 2013;347:15. [Ref.ID 96145]

27.

López A, Costa J. Guía de consenso sobre los contenidos de los protocolos de ensayos clínicos. Med Clin (Barc) 2013;141:161-2. [Ref.ID 96060]

28.

Toussaint B. EU clinical trial regulation. Lancet 2013;381:1719-20. [Ref.ID 95444]

29.

Clark T, Berger U, Mansmann U. Sample size determinations in original research protocols for randomised clinical trials submitted to UK research ethics committees: review. BMJ 2013;346:13. [Ref.ID 95411]

30.

Chan A-W, Telzlaff JM, Altman DG, Laupacis A, Gotzche PC, Krieza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WSM, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200-7. [Ref.ID 94901]

31.

Chan AW, Tetzlaff JM, Altman DG, Dickersin K, Moher D. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet 2013;381:91-2. [Ref.ID 94763]

32.

Gotzsche P. Deficiencies in proposed new EU regulation of clinical trials. BMJ 2013;346:21-3. [Ref.ID 94761]

33.

Chalmers I, Glasziou P, Godlee F. All trials must be registered and the results published. BMJ 2013;346:8. [Ref.ID 94757]

34.

Thornton JG. HRT and cardiovascular events. Press release was misleading. BMJ 2012;345:27. [Ref.ID 94212]

35.

Schierbeck LL, Kober L, Jensen J-EB. HRT and cardiovascular events. Author's reply. BMJ 2012;345:27. [Ref.ID 94211]

36.

McPherson K. HRT and cardiovascular events. Age hypothesis does not stand. BMJ 2012;345:27. [Ref.ID 94210]

37.

Schroll J, Lundh A. HRT and cardiovascular events. Was composite outcome specified in original protocol?. BMJ 2012;345:26-7. [Ref.ID 94209]

38.

Rossouw JE, Manson JE, Kaunitz AM, Stefanick ML. HRT and cardiovascular events. Safety couldn't be investigated. BMJ 2012;345:26. [Ref.ID 94208]

39.

Marjoribanks J, Farquhar C, Roberts H, Lethaby A. HRT and cardiovascular events. Trial does not change results of Cochrane review. BMJ 2012;345:26. [Ref.ID 94207]

40.

Coombes R. GlaxoSmithKline grants researchers access to raw clinical trial data. BMJ 2012;345:2-3. [Ref.ID 93906]